{"schema_version":"1","generated_at":"2026-10-29T11:52:23.169Z","data_as_of":null,"url":"https://www.findmykol.com/kol/grant-wintheiser","json_url":"https://www.findmykol.com/kol/grant-wintheiser/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"grant-wintheiser","name":"Grant Wintheiser","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Mayo Clinic","institution_url":"https://www.findmykol.com/institution/mayo-clinic","city":"Rochester","state":"MN","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1043770092","orcid":"0000-0003-4492-6342","openalex":"A5030765064"},"summary":"Grant Wintheiser is an Oncology physician affiliated with Mayo Clinic. OpenAlex indexes 10 publications with 203 citations (h-index 6).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":10,"cited_by_count":203,"h_index":6,"latest_activity_year":2022,"source":"works"},"prescribing":{"data_year":2024,"areas_total":5,"areas_shown":3,"areas":[{"area":"Nervous system","share_pct":28.7,"classes_total":3,"classes":[{"class":"Atypical Antipsychotic","setting":"prescribed","share_pct":10.4,"drugs":[{"name":"Olanzapine","share_pct":100}],"max_beneficiaries":null},{"class":"Phenothiazine","setting":"prescribed","share_pct":9.1,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":12}]},{"area":"Metabolism & gastrointestinal","share_pct":28,"classes_total":2,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":17.1,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":null},{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":11,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":13}]},{"area":"Cancer & immunology","share_pct":18.9,"classes_total":2,"classes":[{"class":"Antimetabolite","setting":"prescribed","share_pct":11.6,"drugs":[{"name":"Hydroxyurea","share_pct":100}],"max_beneficiaries":null},{"class":"Kinase inhibitor","setting":"prescribed","share_pct":7.3,"drugs":[{"name":"Tabrecta","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":10,"shown":5,"withheld":5,"matched_by":"OpenAlex author record","recent":[{"title":"Tumor Mutational Burden Is a Potential Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Advanced Biliary Tract Cancer","year":2022,"journal":"JCO Precision Oncology","source_url":"https://doi.org/10.1200/po.22.00003","status":"verified"},{"title":"Reply to F. Nichetti et al","year":2022,"journal":"JCO Precision Oncology","source_url":"https://doi.org/10.1200/po.22.00131","status":"verified"},{"title":"TAS-102: A resurrected novel Fluoropyrimidine with expanding role in the treatment of gastrointestinal malignancies","year":2021,"journal":"Pharmacology & Therapeutics","source_url":"https://doi.org/10.1016/j.pharmthera.2021.107823","status":"verified"},{"title":"Disseminated Nocardia in an Immunocompetent Host","year":2021,"journal":"Mayo Clinic Proceedings","source_url":"https://doi.org/10.1016/j.mayocp.2020.11.019","status":"verified"},{"title":"Receptivity to a Nurse-Led Symptom Management Intervention Among Highly Symptomatic Patients With Cancer","year":2021,"journal":"JNCI Journal of the National Cancer Institute","source_url":"https://doi.org/10.1093/jnci/djab172","status":"verified"}],"source":"works"},"contact":{"address_1":"200 1ST ST SW","city":"Rochester","state":"MN","zip":"559050001","phone":"507-284-2511","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1043770092","source":"identity"},"similar":[{"name":"S Rajkumar","slug":"s-rajkumar","institution":"Mayo Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/s-rajkumar","json_url":"https://www.findmykol.com/kol/s-rajkumar/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"},{"name":"Victor Montori","slug":"victor-montori","institution":"Mayo Clinic","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/victor-montori","json_url":"https://www.findmykol.com/kol/victor-montori/profile.json"},{"name":"Ayalew Tefferi","slug":"ayalew-tefferi","institution":"Mayo Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/ayalew-tefferi","json_url":"https://www.findmykol.com/kol/ayalew-tefferi/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":5}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-06-04","provider_certified":"2025-06-04","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}